(Alliance News) - Clinigen Group PLC on Tuesday, following its annual general meeting, reiterated its adjusted gross profit guidance for its current financial year ending June 30, 2020.
The pharmaceutical services firm said adjusted gross profit is set to increase at the upper half of its guidance of 5% to 10%. In September, Clinigen said the increase would be driven by continued growth in Clinical Services and developed assets in Commercial Medicines.
At the meeting, Clinigen said that all resolutions were passed.
Shares in Clinigen closed up 1.2% at 865.0 pence Tuesday in London.
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2019 Alliance News Limited. All Rights Reserved.
